Cargando…

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older

BACKGROUND: Monitoring safety outcomes following COVID-19 vaccination is critical for understanding vaccine safety especially when used in key populations such as elderly persons age 65 years and older who can benefit greatly from vaccination. We present new findings from a nationally representative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Hui-Lee, Tworkoski, Ellen, Ke Zhou, Cindy, Hu, Mao, Thompson, Deborah, Lufkin, Bradley, Do, Rose, Feinberg, Laurie, Chillarige, Yoganand, Dimova, Rositsa, Lloyd, Patricia C., MaCurdy, Thomas, Forshee, Richard A., Kelman, Jeffrey A., Shoaibi, Azadeh, Anderson, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712075/ https://www.ncbi.nlm.nih.gov/pubmed/36496287 http://dx.doi.org/10.1016/j.vaccine.2022.11.069

Ejemplares similares

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020
por: Moll, Keran, et al.
Publicado: (2023)

Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
por: Shoaibi, Azadeh, et al.
Publicado: (2023)

1173. Risk of Pneumococcal Disease and Rate of Pneumococcal Vaccination Among Medicare Beneficiaries Aged 65 Years and Older Residing in Long-Term Care Facilities — United States, September 1, 2014 – December 31, 2019
por: Kobyashi, Miwako, et al.
Publicado: (2023)

2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017
por: Lessa, Fernanda C, et al.
Publicado: (2019)

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
por: Lloyd, Patricia C., et al.
Publicado: (2022)

Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States
por: Dahlgren, F. Scott, et al.
Publicado: (2018)

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data
por: Dahlgren, F. Scott, et al.
Publicado: (2018)

Use of Immunization Information Systems in Ascertainment of COVID-19 Vaccinations for Claims-Based Vaccine Safety and Effectiveness Studies
por: Schneider, Karen L., et al.
Publicado: (2023)

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
por: Wong, Hui-Lee, et al.
Publicado: (2022)

Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension
por: Graham, David J., et al.
Publicado: (2021)

Need for Risk Adjustment in Adapting Episode Grouping Software to Medicare Data
por: MaCurdy, Thomas, et al.
Publicado: (2009)

Babesiosis among Elderly Medicare Beneficiaries, United States, 2006–2008
por: Menis, Mikhail, et al.
Publicado: (2012)

The effect of the rate of hydrostatic pressure depressurization on cells in culture
por: Tworkoski, Ellen, et al.
Publicado: (2018)

2219. Evaluation of Medicare Claims to Assess Burden of Pertussis Disease in Persons Aged ≥65 Years
por: Havers, Fiona, et al.
Publicado: (2019)

Medicine at Yale: The First 200 Years
por: Tworkoski, Kathryn
Publicado: (2011)

Practical Hematopoietic Stem Cell Transplantation
por: Tworkoski, Kathryn
Publicado: (2009)

Translational Medicine and Drug Discovery
por: Tworkoski, Kathryn
Publicado: (2011)

Becoming a Successful Scientist: Strategic Thinking for Scientific Discovery
por: Tworkoski, Kathryn
Publicado: (2011)

Molecular Pathology in Drug Discovery and Development
por: Tworkoski, Kathryn
Publicado: (2010)

Companion animal disease surveillance: A new solution to an old problem?
por: Ward, M.P., et al.
Publicado: (2011)

Inappropriate statistical method in a parallel-group randomized controlled trial results in unsubstantiated conclusions
por: Dimova, Rositsa B., et al.
Publicado: (2016)

The EUROPEP questionnaire for patient’s evaluation of general practice care: Bulgarian experience
por: Dimova, Rositsa, et al.
Publicado: (2017)

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
por: Woo, Emily Jane, et al.
Publicado: (2022)

Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February–November 2020
por: Saunders-Hastings, Patrick, et al.
Publicado: (2022)

Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival
por: Lufkin, Leon, et al.
Publicado: (2022)

Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018*
por: Buchman, Timothy G., et al.
Publicado: (2020)

Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018*
por: Buchman, Timothy G., et al.
Publicado: (2020)

Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018*
por: Buchman, Timothy G., et al.
Publicado: (2020)

$\beta^{-}$ decay of $^{65}$Mn to $^{65}$Fe
por: Olaizola, B., et al.
Publicado: (2013)

Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual Sites
por: Hobbi, Shayan, et al.
Publicado: (2023)

Linguistic Validation and Cultural Adaptation of Bulgarian Version of Hospital Survey on Patient Safety Culture (HSOPSC)
por: Stoyanova, Rumyana, et al.
Publicado: (2018)

Case Report: Multisystem Autoimmune and Overlapping GAD65-Antibody-Associated Neurological Disorders With Beneficial Effect of Epilepsy Surgery and Rituximab Treatment
por: Dimova, Petia, et al.
Publicado: (2022)

Characterization of COVID-19 Hospitalized Patients in Three United States Electronic Health Record Databases
por: Saunders-Hastings, Patrick, et al.
Publicado: (2023)

Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012–February 2020
por: Frank, Charles E., et al.
Publicado: (2021)

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022
por: Woo, Emily Jane, et al.
Publicado: (2023)

A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data
por: Nelson, Jennifer C., et al.
Publicado: (2016)

65 years of influenza surveillance by a World Health Organization‐coordinated global network
por: Ziegler, Thedi, et al.
Publicado: (2018)

Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
por: Dimova, Rositsa, et al.
Publicado: (2019)

Activity of Delafloxacin When Tested Against Bacterial Surveillance Isolates Collected in the US and Europe During 2014–2016 as Part of a Global Surveillance Program
por: Flamm, Robert K, et al.
Publicado: (2017)

Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results
por: Moll, Keran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_er2ofp7n1h9rhtjergdnb6b6o4